Loading…
Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligands
Summary The reaction of the heterocyclic thiol derivatives, 2-mercapto-1-methylimidazole (SH-imi), 5-mercapto-1-methyltetrazole (SH-tet), 2-mercaptobenzothiazole (SH-ben) and 5-phenyl-1,3,4-oxadiazole-2-thiol (SH-oxa), with trimethylgallium (1:1) afforded the dimeric or tetrameric complexes [Me 2 Ga...
Saved in:
Published in: | Investigational new drugs 2011-10, Vol.29 (5), p.932-944 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c404t-b2c921406c8b817e3acdd2d0a0457f6795bf94f1678bbbb7b82a9707fb60230e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c404t-b2c921406c8b817e3acdd2d0a0457f6795bf94f1678bbbb7b82a9707fb60230e3 |
container_end_page | 944 |
container_issue | 5 |
container_start_page | 932 |
container_title | Investigational new drugs |
container_volume | 29 |
creator | Gallego, Beatriz Kaluđerović, Milena R. Kommera, Harish Paschke, Reinhard Hey-Hawkins, Evamarie Remmerbach, Torsten W. Kaluđerović, Goran N. Gómez-Ruiz, Santiago |
description | Summary
The reaction of the heterocyclic thiol derivatives, 2-mercapto-1-methylimidazole (SH-imi), 5-mercapto-1-methyltetrazole (SH-tet), 2-mercaptobenzothiazole (SH-ben) and 5-phenyl-1,3,4-oxadiazole-2-thiol (SH-oxa), with trimethylgallium (1:1) afforded the dimeric or tetrameric complexes [Me
2
Ga(S-imi)]
2
(
1
), [Me
2
Ga(S-tet)]
2
(
2
), [Me
2
Ga(S-ben)]
2
(
3
) and [Me
2
Ga(S-oxa)]
4
(
4
), respectively. Molecular structures of
2
and
4
were determined by X-ray diffraction studies. The cytotoxicity of the gallium(III) complexes
1
–
4
was tested against human cell lines 8505C anaplastic thyroid cancer, A253 head and neck tumor, A549 lung carcinoma, A2780 ovarian cancer, DLD-1 colon carcinoma and compared with those of cisplatin and Ga(NO
3
)
3
. Compound
4
seems to be slightly more active against 8505C, A253 and A2780 and substantially more active than all the other complexes against DLD-1, with an IC
50
value of 5.49 ± 0.16 µM, very close to that of cisplatin (5.14 ± 0.12 µM). Complexes
1
–
4
were less toxic on normal human fibroblasts (WWO70327) than on the investigated tumor cell lines and more selective to cancer cells than cisplatin. DNA laddering method showed that treatment of the DLD-1 cell line with IC
90
doses of
1
–
4
resulted in the induction of apoptosis. Compound
1
caused apoptosis by upregulation of caspases 2, 3 and 8. Since no activity of caspase 9 is observed, complex
1
is causing apoptosis triggered by an extrinsic pathway. DNA-interaction tests have been also carried out. Solutions of all the studied complexes have been treated with different concentrations of fish sperm DNA (FS-DNA). Modifications of the UV spectra which gave intrinsic binding constants of 3.03 × 10
5
, 4.44 × 10
5
, 3.02 × 10
6
and 5.56 × 10
5
M
−1
for
1
–
4
were observed, however, no notable interaction with pBR322 plasmid DNA was detected. |
doi_str_mv | 10.1007/s10637-010-9449-8 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1439230777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1439230777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c404t-b2c921406c8b817e3acdd2d0a0457f6795bf94f1678bbbb7b82a9707fb60230e3</originalsourceid><addsrcrecordid>eNp1kUFvFCEUx4mxsWv1A3gxJF5qIvqYYYfh2Ky2btLoRc8EGGaXhhlGYNLOx_Abl3WrMU3K5R3e7_2B90PoDYWPFIB_ShSamhOgQARjgrTP0IqueU2gYc1ztALacNIIwU_Ry5RuAKAWnL1ApxWwhrctW6HfmyWHHO6ccXn5gNUUphySS1iNHU557hYcepz3Fn_-dkG0Gzs37vAUw2RjdjYdutqRP3i2OapxNt6qiHfKezcP59vt9j02YZi8vSv4rct7vLfZxmAW450p2S54lQP2bldS0it00iuf7OuHeoZ-Xn75sflKrr9fbTcX18QwYJnoyoiKMmhMq1vKba1M11UdKGBr3jdcrHUvWF820OpyuG4rJTjwXjdQ1WDrM3R-zC2f-TXblOXgkrHeq9GGOUnKalFAznlB3z1Cb8Icx_I6SSmtaE1FKwpFj5SJIaVoezlFN6i4SAry4EsefcniSx58ybbMvH1InvVgu38TfwUVoDoCqbTGnY3_Xf1k6j2B5aHn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1112131989</pqid></control><display><type>article</type><title>Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligands</title><source>ABI/INFORM Global</source><source>Springer Link</source><creator>Gallego, Beatriz ; Kaluđerović, Milena R. ; Kommera, Harish ; Paschke, Reinhard ; Hey-Hawkins, Evamarie ; Remmerbach, Torsten W. ; Kaluđerović, Goran N. ; Gómez-Ruiz, Santiago</creator><creatorcontrib>Gallego, Beatriz ; Kaluđerović, Milena R. ; Kommera, Harish ; Paschke, Reinhard ; Hey-Hawkins, Evamarie ; Remmerbach, Torsten W. ; Kaluđerović, Goran N. ; Gómez-Ruiz, Santiago</creatorcontrib><description>Summary
The reaction of the heterocyclic thiol derivatives, 2-mercapto-1-methylimidazole (SH-imi), 5-mercapto-1-methyltetrazole (SH-tet), 2-mercaptobenzothiazole (SH-ben) and 5-phenyl-1,3,4-oxadiazole-2-thiol (SH-oxa), with trimethylgallium (1:1) afforded the dimeric or tetrameric complexes [Me
2
Ga(S-imi)]
2
(
1
), [Me
2
Ga(S-tet)]
2
(
2
), [Me
2
Ga(S-ben)]
2
(
3
) and [Me
2
Ga(S-oxa)]
4
(
4
), respectively. Molecular structures of
2
and
4
were determined by X-ray diffraction studies. The cytotoxicity of the gallium(III) complexes
1
–
4
was tested against human cell lines 8505C anaplastic thyroid cancer, A253 head and neck tumor, A549 lung carcinoma, A2780 ovarian cancer, DLD-1 colon carcinoma and compared with those of cisplatin and Ga(NO
3
)
3
. Compound
4
seems to be slightly more active against 8505C, A253 and A2780 and substantially more active than all the other complexes against DLD-1, with an IC
50
value of 5.49 ± 0.16 µM, very close to that of cisplatin (5.14 ± 0.12 µM). Complexes
1
–
4
were less toxic on normal human fibroblasts (WWO70327) than on the investigated tumor cell lines and more selective to cancer cells than cisplatin. DNA laddering method showed that treatment of the DLD-1 cell line with IC
90
doses of
1
–
4
resulted in the induction of apoptosis. Compound
1
caused apoptosis by upregulation of caspases 2, 3 and 8. Since no activity of caspase 9 is observed, complex
1
is causing apoptosis triggered by an extrinsic pathway. DNA-interaction tests have been also carried out. Solutions of all the studied complexes have been treated with different concentrations of fish sperm DNA (FS-DNA). Modifications of the UV spectra which gave intrinsic binding constants of 3.03 × 10
5
, 4.44 × 10
5
, 3.02 × 10
6
and 5.56 × 10
5
M
−1
for
1
–
4
were observed, however, no notable interaction with pBR322 plasmid DNA was detected.</description><identifier>ISSN: 0167-6997</identifier><identifier>EISSN: 1573-0646</identifier><identifier>DOI: 10.1007/s10637-010-9449-8</identifier><identifier>PMID: 20467884</identifier><identifier>CODEN: INNDDK</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Apoptosis ; Apoptosis - drug effects ; Cancer therapies ; Caspases - metabolism ; Cell Line, Tumor ; Cell Survival - drug effects ; Chemotherapy ; Crystallography, X-Ray ; Cytotoxicity ; DNA - metabolism ; DNA Fragmentation - drug effects ; Drug Screening Assays, Antitumor ; Drugs ; Gallium - pharmacology ; Heterocyclic Compounds - chemical synthesis ; Heterocyclic Compounds - chemistry ; Heterocyclic Compounds - pharmacology ; Humans ; Inhibitory Concentration 50 ; Ligands ; Medicine ; Medicine & Public Health ; Models, Molecular ; Nitrates ; Oncology ; Ovarian cancer ; Pharmacology ; Pharmacology/Toxicology ; Plasmids - genetics ; Preclinical Studies ; Spectrophotometry, Ultraviolet ; Studies ; Sulfhydryl Compounds - chemical synthesis ; Sulfhydryl Compounds - chemistry ; Sulfhydryl Compounds - pharmacology ; Thyroid cancer</subject><ispartof>Investigational new drugs, 2011-10, Vol.29 (5), p.932-944</ispartof><rights>Springer Science+Business Media, LLC 2010</rights><rights>Springer Science+Business Media, LLC 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c404t-b2c921406c8b817e3acdd2d0a0457f6795bf94f1678bbbb7b82a9707fb60230e3</citedby><cites>FETCH-LOGICAL-c404t-b2c921406c8b817e3acdd2d0a0457f6795bf94f1678bbbb7b82a9707fb60230e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1112131989/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1112131989?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,11688,27924,27925,36060,36061,44363,74895</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20467884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gallego, Beatriz</creatorcontrib><creatorcontrib>Kaluđerović, Milena R.</creatorcontrib><creatorcontrib>Kommera, Harish</creatorcontrib><creatorcontrib>Paschke, Reinhard</creatorcontrib><creatorcontrib>Hey-Hawkins, Evamarie</creatorcontrib><creatorcontrib>Remmerbach, Torsten W.</creatorcontrib><creatorcontrib>Kaluđerović, Goran N.</creatorcontrib><creatorcontrib>Gómez-Ruiz, Santiago</creatorcontrib><title>Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligands</title><title>Investigational new drugs</title><addtitle>Invest New Drugs</addtitle><addtitle>Invest New Drugs</addtitle><description>Summary
The reaction of the heterocyclic thiol derivatives, 2-mercapto-1-methylimidazole (SH-imi), 5-mercapto-1-methyltetrazole (SH-tet), 2-mercaptobenzothiazole (SH-ben) and 5-phenyl-1,3,4-oxadiazole-2-thiol (SH-oxa), with trimethylgallium (1:1) afforded the dimeric or tetrameric complexes [Me
2
Ga(S-imi)]
2
(
1
), [Me
2
Ga(S-tet)]
2
(
2
), [Me
2
Ga(S-ben)]
2
(
3
) and [Me
2
Ga(S-oxa)]
4
(
4
), respectively. Molecular structures of
2
and
4
were determined by X-ray diffraction studies. The cytotoxicity of the gallium(III) complexes
1
–
4
was tested against human cell lines 8505C anaplastic thyroid cancer, A253 head and neck tumor, A549 lung carcinoma, A2780 ovarian cancer, DLD-1 colon carcinoma and compared with those of cisplatin and Ga(NO
3
)
3
. Compound
4
seems to be slightly more active against 8505C, A253 and A2780 and substantially more active than all the other complexes against DLD-1, with an IC
50
value of 5.49 ± 0.16 µM, very close to that of cisplatin (5.14 ± 0.12 µM). Complexes
1
–
4
were less toxic on normal human fibroblasts (WWO70327) than on the investigated tumor cell lines and more selective to cancer cells than cisplatin. DNA laddering method showed that treatment of the DLD-1 cell line with IC
90
doses of
1
–
4
resulted in the induction of apoptosis. Compound
1
caused apoptosis by upregulation of caspases 2, 3 and 8. Since no activity of caspase 9 is observed, complex
1
is causing apoptosis triggered by an extrinsic pathway. DNA-interaction tests have been also carried out. Solutions of all the studied complexes have been treated with different concentrations of fish sperm DNA (FS-DNA). Modifications of the UV spectra which gave intrinsic binding constants of 3.03 × 10
5
, 4.44 × 10
5
, 3.02 × 10
6
and 5.56 × 10
5
M
−1
for
1
–
4
were observed, however, no notable interaction with pBR322 plasmid DNA was detected.</description><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Cancer therapies</subject><subject>Caspases - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival - drug effects</subject><subject>Chemotherapy</subject><subject>Crystallography, X-Ray</subject><subject>Cytotoxicity</subject><subject>DNA - metabolism</subject><subject>DNA Fragmentation - drug effects</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Drugs</subject><subject>Gallium - pharmacology</subject><subject>Heterocyclic Compounds - chemical synthesis</subject><subject>Heterocyclic Compounds - chemistry</subject><subject>Heterocyclic Compounds - pharmacology</subject><subject>Humans</subject><subject>Inhibitory Concentration 50</subject><subject>Ligands</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Models, Molecular</subject><subject>Nitrates</subject><subject>Oncology</subject><subject>Ovarian cancer</subject><subject>Pharmacology</subject><subject>Pharmacology/Toxicology</subject><subject>Plasmids - genetics</subject><subject>Preclinical Studies</subject><subject>Spectrophotometry, Ultraviolet</subject><subject>Studies</subject><subject>Sulfhydryl Compounds - chemical synthesis</subject><subject>Sulfhydryl Compounds - chemistry</subject><subject>Sulfhydryl Compounds - pharmacology</subject><subject>Thyroid cancer</subject><issn>0167-6997</issn><issn>1573-0646</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>M0C</sourceid><recordid>eNp1kUFvFCEUx4mxsWv1A3gxJF5qIvqYYYfh2Ky2btLoRc8EGGaXhhlGYNLOx_Abl3WrMU3K5R3e7_2B90PoDYWPFIB_ShSamhOgQARjgrTP0IqueU2gYc1ztALacNIIwU_Ry5RuAKAWnL1ApxWwhrctW6HfmyWHHO6ccXn5gNUUphySS1iNHU557hYcepz3Fn_-dkG0Gzs37vAUw2RjdjYdutqRP3i2OapxNt6qiHfKezcP59vt9j02YZi8vSv4rct7vLfZxmAW450p2S54lQP2bldS0it00iuf7OuHeoZ-Xn75sflKrr9fbTcX18QwYJnoyoiKMmhMq1vKba1M11UdKGBr3jdcrHUvWF820OpyuG4rJTjwXjdQ1WDrM3R-zC2f-TXblOXgkrHeq9GGOUnKalFAznlB3z1Cb8Icx_I6SSmtaE1FKwpFj5SJIaVoezlFN6i4SAry4EsefcniSx58ybbMvH1InvVgu38TfwUVoDoCqbTGnY3_Xf1k6j2B5aHn</recordid><startdate>20111001</startdate><enddate>20111001</enddate><creator>Gallego, Beatriz</creator><creator>Kaluđerović, Milena R.</creator><creator>Kommera, Harish</creator><creator>Paschke, Reinhard</creator><creator>Hey-Hawkins, Evamarie</creator><creator>Remmerbach, Torsten W.</creator><creator>Kaluđerović, Goran N.</creator><creator>Gómez-Ruiz, Santiago</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>K60</scope><scope>K6~</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>L.-</scope><scope>M0C</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7TM</scope></search><sort><creationdate>20111001</creationdate><title>Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligands</title><author>Gallego, Beatriz ; Kaluđerović, Milena R. ; Kommera, Harish ; Paschke, Reinhard ; Hey-Hawkins, Evamarie ; Remmerbach, Torsten W. ; Kaluđerović, Goran N. ; Gómez-Ruiz, Santiago</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c404t-b2c921406c8b817e3acdd2d0a0457f6795bf94f1678bbbb7b82a9707fb60230e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Cancer therapies</topic><topic>Caspases - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival - drug effects</topic><topic>Chemotherapy</topic><topic>Crystallography, X-Ray</topic><topic>Cytotoxicity</topic><topic>DNA - metabolism</topic><topic>DNA Fragmentation - drug effects</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Drugs</topic><topic>Gallium - pharmacology</topic><topic>Heterocyclic Compounds - chemical synthesis</topic><topic>Heterocyclic Compounds - chemistry</topic><topic>Heterocyclic Compounds - pharmacology</topic><topic>Humans</topic><topic>Inhibitory Concentration 50</topic><topic>Ligands</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Models, Molecular</topic><topic>Nitrates</topic><topic>Oncology</topic><topic>Ovarian cancer</topic><topic>Pharmacology</topic><topic>Pharmacology/Toxicology</topic><topic>Plasmids - genetics</topic><topic>Preclinical Studies</topic><topic>Spectrophotometry, Ultraviolet</topic><topic>Studies</topic><topic>Sulfhydryl Compounds - chemical synthesis</topic><topic>Sulfhydryl Compounds - chemistry</topic><topic>Sulfhydryl Compounds - pharmacology</topic><topic>Thyroid cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gallego, Beatriz</creatorcontrib><creatorcontrib>Kaluđerović, Milena R.</creatorcontrib><creatorcontrib>Kommera, Harish</creatorcontrib><creatorcontrib>Paschke, Reinhard</creatorcontrib><creatorcontrib>Hey-Hawkins, Evamarie</creatorcontrib><creatorcontrib>Remmerbach, Torsten W.</creatorcontrib><creatorcontrib>Kaluđerović, Goran N.</creatorcontrib><creatorcontrib>Gómez-Ruiz, Santiago</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Global</collection><collection>ProQuest Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Nucleic Acids Abstracts</collection><jtitle>Investigational new drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gallego, Beatriz</au><au>Kaluđerović, Milena R.</au><au>Kommera, Harish</au><au>Paschke, Reinhard</au><au>Hey-Hawkins, Evamarie</au><au>Remmerbach, Torsten W.</au><au>Kaluđerović, Goran N.</au><au>Gómez-Ruiz, Santiago</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligands</atitle><jtitle>Investigational new drugs</jtitle><stitle>Invest New Drugs</stitle><addtitle>Invest New Drugs</addtitle><date>2011-10-01</date><risdate>2011</risdate><volume>29</volume><issue>5</issue><spage>932</spage><epage>944</epage><pages>932-944</pages><issn>0167-6997</issn><eissn>1573-0646</eissn><coden>INNDDK</coden><abstract>Summary
The reaction of the heterocyclic thiol derivatives, 2-mercapto-1-methylimidazole (SH-imi), 5-mercapto-1-methyltetrazole (SH-tet), 2-mercaptobenzothiazole (SH-ben) and 5-phenyl-1,3,4-oxadiazole-2-thiol (SH-oxa), with trimethylgallium (1:1) afforded the dimeric or tetrameric complexes [Me
2
Ga(S-imi)]
2
(
1
), [Me
2
Ga(S-tet)]
2
(
2
), [Me
2
Ga(S-ben)]
2
(
3
) and [Me
2
Ga(S-oxa)]
4
(
4
), respectively. Molecular structures of
2
and
4
were determined by X-ray diffraction studies. The cytotoxicity of the gallium(III) complexes
1
–
4
was tested against human cell lines 8505C anaplastic thyroid cancer, A253 head and neck tumor, A549 lung carcinoma, A2780 ovarian cancer, DLD-1 colon carcinoma and compared with those of cisplatin and Ga(NO
3
)
3
. Compound
4
seems to be slightly more active against 8505C, A253 and A2780 and substantially more active than all the other complexes against DLD-1, with an IC
50
value of 5.49 ± 0.16 µM, very close to that of cisplatin (5.14 ± 0.12 µM). Complexes
1
–
4
were less toxic on normal human fibroblasts (WWO70327) than on the investigated tumor cell lines and more selective to cancer cells than cisplatin. DNA laddering method showed that treatment of the DLD-1 cell line with IC
90
doses of
1
–
4
resulted in the induction of apoptosis. Compound
1
caused apoptosis by upregulation of caspases 2, 3 and 8. Since no activity of caspase 9 is observed, complex
1
is causing apoptosis triggered by an extrinsic pathway. DNA-interaction tests have been also carried out. Solutions of all the studied complexes have been treated with different concentrations of fish sperm DNA (FS-DNA). Modifications of the UV spectra which gave intrinsic binding constants of 3.03 × 10
5
, 4.44 × 10
5
, 3.02 × 10
6
and 5.56 × 10
5
M
−1
for
1
–
4
were observed, however, no notable interaction with pBR322 plasmid DNA was detected.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>20467884</pmid><doi>10.1007/s10637-010-9449-8</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0167-6997 |
ispartof | Investigational new drugs, 2011-10, Vol.29 (5), p.932-944 |
issn | 0167-6997 1573-0646 |
language | eng |
recordid | cdi_proquest_miscellaneous_1439230777 |
source | ABI/INFORM Global; Springer Link |
subjects | Apoptosis Apoptosis - drug effects Cancer therapies Caspases - metabolism Cell Line, Tumor Cell Survival - drug effects Chemotherapy Crystallography, X-Ray Cytotoxicity DNA - metabolism DNA Fragmentation - drug effects Drug Screening Assays, Antitumor Drugs Gallium - pharmacology Heterocyclic Compounds - chemical synthesis Heterocyclic Compounds - chemistry Heterocyclic Compounds - pharmacology Humans Inhibitory Concentration 50 Ligands Medicine Medicine & Public Health Models, Molecular Nitrates Oncology Ovarian cancer Pharmacology Pharmacology/Toxicology Plasmids - genetics Preclinical Studies Spectrophotometry, Ultraviolet Studies Sulfhydryl Compounds - chemical synthesis Sulfhydryl Compounds - chemistry Sulfhydryl Compounds - pharmacology Thyroid cancer |
title | Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligands |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A11%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytotoxicity,%20apoptosis%20and%20study%20of%20the%20DNA-binding%20properties%20of%20bi-%20and%20tetranuclear%20gallium(III)%20complexes%20with%20heterocyclic%20thiolato%20ligands&rft.jtitle=Investigational%20new%20drugs&rft.au=Gallego,%20Beatriz&rft.date=2011-10-01&rft.volume=29&rft.issue=5&rft.spage=932&rft.epage=944&rft.pages=932-944&rft.issn=0167-6997&rft.eissn=1573-0646&rft.coden=INNDDK&rft_id=info:doi/10.1007/s10637-010-9449-8&rft_dat=%3Cproquest_cross%3E1439230777%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c404t-b2c921406c8b817e3acdd2d0a0457f6795bf94f1678bbbb7b82a9707fb60230e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1112131989&rft_id=info:pmid/20467884&rfr_iscdi=true |